Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaveAu who wrote (1723)	5/4/1999 8:51:00 AM
From: Montana Wildhack	of 14101

Results from an earlier well-controlled clinical trial at Vanderbilt University in Nashville, TN were published in the journal Infection (August 1998). The study indicated that AIDS patients receiving WF10 experienced a lower frequency of opportunistic infections, fewer hospitalizations, and longer survival. As I recall the results were dramatic. None of the patients receiving placebo survived, while most getting WF10 did survive and more compelling - the patients getting WF10 needed virtually no hospital days while the placebo group needed many.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next